|2.||Vertigo (Positional Vertigo)
|1.||Munro, Kevin J: 4 articles (07/2015 - 01/2012)|
|2.||Balzer, Jeffrey: 3 articles (12/2015 - 04/2013)|
|3.||Thirumala, Parthasarathy: 3 articles (12/2015 - 04/2013)|
|4.||Gstoettner, Wolfgang: 3 articles (10/2011 - 04/2009)|
|5.||Wagenblast, Jens: 3 articles (10/2011 - 04/2009)|
|6.||Arnoldner, Christoph: 3 articles (10/2011 - 04/2009)|
|7.||Crammond, Donald: 2 articles (12/2015 - 10/2015)|
|8.||Habeych, Miguel: 2 articles (12/2015 - 04/2013)|
|9.||Ellis, Rachel J: 2 articles (07/2015 - 01/2015)|
|10.||Moreno, Felipe: 2 articles (05/2014 - 02/2008)|
01/01/2009 - "After a negative magnetic resonance scan of the brain, he remembered his sister's experience with aspartame and stopped his consumption of aspartame with resolution of his symptoms, although the very high frequency hearing loss took at least 15 months to resolve. "
01/01/2009 - "Even though the yield may be low, asking patients with dizziness, vertigo, tinnitus, or high-frequency hearing loss about their aspartame consumption and suggesting cessation of its use, may prove helpful for some."
|2.||rituximab (Mabthera)FDA Link
|3.||Cisplatin (Platino)FDA LinkGeneric
06/01/2006 - "Cisplatin caused a sensorineural high-frequency hearing loss in the study group compared to the controls (p < 0.01). "
11/01/2004 - "The aim of this study was to determine the risk factors for high-frequency hearing loss in children treated with cisplatin. "
12/01/2008 - "Bilateral symmetric high frequency hearing loss is regarded as one of the main characteristics of cisplatin-induced ototoxicity. "
09/01/2007 - "Thus, we conclude that high-frequency hearing loss remains a potentially serious and permanent adverse effect of cisplatin."
11/01/2004 - "Age at treatment and the cumulative dose of cisplatin were the two most important risk factors in predicting moderate to severe high-frequency hearing loss in children treated with cisplatin."
|4.||Gentamicins (Gentamicin)FDA LinkGeneric
04/01/2012 - "Gentamycin-induced progressive high-frequency hearing loss of 45-55 dB SPL. "
03/01/2012 - "These two characteristics may account for the high-frequency hearing loss and vestibular dysfunction seen with use of this system to deliver gentamicin into the inner ear."
03/01/2004 - "Gentamicin induced progressive high-frequency hearing loss of 50-60 dB SPL. "
01/01/2003 - "Gentamicin induced a consistent reduction in VOR responses and a progressive high-frequency hearing loss of 50-60 dB sound pressure level. "
11/01/1991 - "After 5 days of gentamicin exposure, there was near complete basal hair cell loss associated with a high-frequency hearing loss. "
02/01/2009 - "We conclude that a significant rate of high-frequency hearing loss in older patients receiving vancomycin monotherapy was detected by audiometry. "
02/01/2009 - "Analysis of 89 patients for whom audiograms were performed after an average of 27 days of vancomycin therapy showed a 12% rate of high-frequency hearing loss, with a trend in univariate analysis toward a higher rate with advanced age. "
02/01/2009 - "We evaluated the rate of high-frequency hearing loss detected by audiometry for patients on vancomycin therapy. "
12/01/2011 - "The present study suggests that intraperitoneal aminoglycoside and vancomycin administration in CAPD patients may cause low- and high-frequency hearing loss, and this ototoxic effect is related to the dose given. "
|6.||NG-Nitroarginine Methyl Ester (L-NAME)IBA
|7.||Nitric Oxide (Nitrogen Monoxide)FDA Link
|8.||Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/01/1995 - "However, such therapy is associated with unexpected high-frequency hearing loss; even so, on the basis of the favorable responses in patients with primitive neuroectodermal tumors, germ cell tumors, and lymphomas, the study of this regimen for those tumors is being extended in a multiinstitutional trial that also includes cytoxan to further evaluate the potential enhanced drug delivery."
|9.||Complement System Proteins (Complement)IBA
|10.||Blood Glucose (Blood Sugar)IBA
|1.||Hearing Aids (Hearing Aid)
01/01/2008 - "For some individuals with severe high-frequency hearing loss, hearing aids cannot provide a satisfactory improvement in speech recognition. "
07/01/2015 - "Twelve experienced hearing-aid users (aged 65-84 years old) with moderate-to-severe high-frequency hearing loss took part in the study. "
01/01/2015 - "Twelve experienced hearing-aid users (aged 65-84 years old) with moderate-to-severe high-frequency hearing loss participated in the study. "
07/01/2002 - "This study compared the real-ear response provided by custom-fit hearing aids to the closest matching fixed-format disposable hearing aids in patients with precipitous high-frequency hearing loss. "
02/01/1989 - "Results of the study demonstrated that patients with minimal high-frequency hearing loss can benefit from the use of hearing aids. "
02/01/2014 - "This large review found an association of TM perforation size with surgical success and an improvement in speech reception threshold, air conduction at 250 to 2000 Hz, air-bone gap at 500 to 2000 Hz, and worsening bone conduction at 4000 Hz. Patients with high-frequency hearing loss due to TM perforation should not anticipate significant recovery from type I tympanoplasty. "
01/01/1989 - "Sensorineural high-frequency hearing loss after drill-generated acoustic trauma in tympanoplasty."
04/01/2013 - "The primary aim of this study was to evaluate the incidence and discuss the pathogenesis of high-frequency hearing loss (HFHL) after microvascular decompression (MVD) for hemifacial spasm (HFS). "
10/01/2015 - "Reduction in high-frequency hearing loss following technical modifications to microvascular decompression for hemifacial spasm."
04/01/2013 - "Incidence of high-frequency hearing loss after microvascular decompression for hemifacial spasm."
09/01/1991 - "Compound action potentials (CAP) were recorded from the exposed intracranial portion of the eighth nerve to stimulation with click sounds in patients with sensorineural high-frequency hearing loss who underwent microvascular decompression (MVD) operations to treat trigeminal neuralgia (TN). "
12/01/2015 - "OBJECT The primary aim of this study was to evaluate the incidence and discuss the pathogenesis of high-frequency hearing loss (HFHL) after microvascular decompression (MVD) for trigeminal neuralgia (TGN), glossopharyngeal neuralgia (GPN), or geniculate neuralgia (GN). "
|4.||Ossicular Prosthesis (TORP)
09/01/2007 - "The aim of the study was the evaluation of rehabilitation of patients with high frequency hearing loss with the active middle ear implant Vibrant Soundbridge. "
01/01/2008 - "[Application of the middle ear implant in case of high frequency hearing loss--case study]."
09/01/2007 - "[Rehabilitation of high frequency hearing loss: use of an active middle ear implant]."
09/01/2003 - "To assess and compare the benefits for patients with high-frequency hearing loss obtained from an implantable middle ear implant, the Symphonix Vibrant Soundbridge using the SIGNIA processing circuitry, to those derived from conventional amplification using the same integrated circuitry and to those derived from a variety of preoperatively worn hearing aids. "
|5.||Continuous Ambulatory Peritoneal Dialysis (CAPD)